drugset / Trial / NCT00169559

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

NCT00169559

Phase 2 Completed 250 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

An eight week comparison of the investigational drug GW590735, placebo, and the marketed drug fenofibrate intended to increase the levels of "good cholesterol" and decrease levels of "bad cholesterol" in healthy patients with low levels of good cholesterol and high levels of bad cholesterol.

Timeline

Start
2003-11
Primary completion
2005-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenofibrate Small molecule
Comparator GW590735 Small molecule 1 ug
Comparator GW590735 Small molecule 20 ug

Indications